Yuav Ua Li Cas Tirzepatide Synthesized: Fmoc SPPS Mechanism Piav Qhia Ib Kauj Ruam (2026 Qhia)

Khoom -theem peptide synthesis (SPPS) yog qhov tseem ceeb ntawm kev tsim khoom siv thev naus laus zis rau kev kho peptides, thiab tib txoj hauv kev ua lag luam mus ntev - saw peptides nrog 30+ amino acids.

Ua ntej tsim los ua cov txheej txheem tsim kom muaj peev xwm, lub hauv paus ntsiab lus tseem ceeb ntawm SPPS yog anchoring C-terminal amino acid ntawm lub hom phiaj peptide mus rau qhov tsis txaus ntseeg polymer resin kev txhawb nqa, tom qab ntawd txuas ntxiv cov saw peptide ib qho seem ntawm ib lub sijhawm los ntawm C-terminus rau N-terminus. Core solid phase resin chemistry dictates tias cov resin matrix tseem insoluble nyob rau hauv tag nrho cov tshuaj tiv thaiv cov kauj ruam, yog li ntau reagents, byproducts thiab unreacted molecules raug tshem tawm los ntawm yooj yim solvent ntxuav - tshem tawm qhov xav tau rau nruab nrab purification ntawm txhua peptide fragment, lub ntsiab bottleneck ntawm tsoos kua synsethesis {{5}.

Fmoc tiv thaiv lub tswv yim yog tus qauv thoob ntiaj teb rau kev lag luam niaj hnub SPPS. Fmoc deprotection mechanism nyob ntawm lub hauv paus-catalyzed cleavage ntawm carbamate daim ntawv cog lus, siv cov tshuaj piperidine me me uas khaws cia sab- saw tiv thaiv pab pawg thaum nthuav tawm N-terminal amine rau kev sib txuas tom ntej. Qhov mob me me no yog qhov tseem ceeb rau kev txo qis kev cuam tshuam sab hauv ntev - kev sib txuas ua ke.

Rau kev lag luam - nplai kho peptide ntau lawm, SPPS muab peb qhov zoo tshaj qhov hloov tsis tau:

• Scalable automation: Cov qauv txheej txheem kev sib hloov yog sib xws nrog loj - nplai automated synthesizers, ua kom cov khoom sib xws - mus rau - cov zis tawm los ntawm gram mus rau kilogram nplai.
• Tsawg kawg kev tawm tsam: Stepwise solid-theem anchoring txo cov kev sib tshuam ntawm cov kab sib txuas- cov tshuaj tiv thaiv thiab cov saw tawg, ob qho tib si pervasive defects hauv cov kua-theem ntev-peptide synthesis.
• Qhov chaw meej-kev hloov kho tshwj xeeb: Cov pab pawg ua haujlwm xws li cov saw roj fatty acid hauv tirzepatide tuaj yeem sib txuas ntawm cov haujlwm uas tau hais tseg nrog cov regioselectivity siab, tsis cuam tshuam lwm cov amino acid residues.

Rau peptides ntev dua 30 amino acids, kua-theem synthesis ua rau ze rau-tag nrho cov txiaj ntsig tsis zoo thiab txwv tsis pub cov nqi purification. Qhov no ua rau SPPS tus qauv tsis muaj teeb meem kev lag luam rau kev kho peptide kev tsim khoom hauv xyoo 2026.

Raws li 39-amino-acid linear peptide nrog rau qhov chaw- tshwj xeeb fatty acid sab- chain modification, tirzepatide ntog mus rau qhov ntev -chain peptide qeb, qhov twg SPPS tsis yog ib qho kev xaiv zoo xwb - nws yog qhov tsim nyog.

Peb tus yam ntxwv ua rau SPPS yuav tsum tau ua lag luamTirzepatide APIntau lawm:

• 39-amino-acid ntev caj qaum: Ib daim ntawv qhia tag nrho -ntev 39- seem seem yuav tsum muaj 38 sib law liag peptide daim ntawv cog lus cov kauj ruam. Kev sib xyaw ua kua-theem yuav xav tau kev sib cais thiab ua kom huv tom qab txhua kauj ruam, ua rau cov khoom lag luam poob ntau dua 99% yam tsis muaj kev lag luam.
• High aggregation propensity: Tirzepatide muaj ntau yam hydrophobic amino acid domains, thiab nws cov lipidated sab saw ntxiv tsub kom molecular hydrophobicity. Peptide aggregation nyob rau hauv SPPS yog ib qho zoo -cov ntaub ntawv sib tw rau cov molecule no; nyob rau hauv cov kua-theem systems, loj hlob peptide chains spontaneously sib sau ua ke thiab quav mus rau ib tug ntau dua degree, ua rau hnyav chain breakage thiab off- lub hom phiaj kev tshwm sim.
• Ib sab nruj- cov kev hloov pauv cov saw hlau: Cov fatty acid moiety uas txuas ntxiv tirzepatide txoj kev ncig ib nrab -lub neej yuav tsum tau muab sib txuas rau ib qho lysine residue. Solid-theem synthesis tso cai rau kev xaiv deprotection thiab hloov kho ntawm lub vev xaib no, nrog tsawg kawg tawm - lub hom phiaj reactivity
•  

​

Muaj tirzepatide synthesis siv Fmoc (9-fluorenylmethoxycarbonyl) kev tiv thaiv lub tswv yim, feem ntau siv tau SPPS raws tu qauv rau GMP-qib kho peptides. Cov txheej txheem tag nrho ua raws li lub voj voog rov ua dua uas ua rau cov peptide saw elongation chemistry ib qho seem ntawm ib lub sij hawm, nrog kev tswj xyuas nruj ntawm txhua theem kom txo qis qhov ua tsis tiav.

Kauj Ruam 1: Resin Loading

Synthesis pib los ntawm anchoring Fmoc- tiv thaiv C-terminal amino acid ntawm tirzepatide mus rau cov khoom siv-theem resin (feem ntau Rink Amide resin rau ntev peptide ntau lawm). Loading ceev yog ua tib zoo calibrated: ntau heev hloov pauv nce inter- chain aggregation nyob rau tom qab elongation kauj ruam, thaum overly loading txo batch output efficiency.

Kauj ruam 2: Fmoc Deprotection

Tom qab resin loading thiab hnyav ntxuav, piperidine / DMF cov tshuaj tau qhia kom tshem tawm N-terminal Fmoc tiv thaiv pab pawg, nthuav tawm cov thawj amine dawb npaj rau cov tshuaj tiv thaiv txuas ntxiv tom ntej. Standard Fmoc deprotection siv 20% piperidine hauv DMF nrog 5-10 feeb cov tshuaj tiv thaiv lub sij hawm ntawm chav tsev kub. Cov tshuaj tiv thaiv lub sij hawm thiab reagent concentration yog nruj me ntsis tswj kom tsis txhob ntxov ntxov cleavage ntawm sab - saw tiv thaiv pab pawg, ib tug ntau qhov chaw ntawm impurity nyob rau hauv ntev -peptide ntau lawm.

Kauj Ruam 3: Amino Acid Coupling

Tom ntej no Fmoc- tiv thaiv amino acid nyob rau hauv tirzepatide ib ntus yog ua ntej- qhib nrog lub coupling reagent system (tus qauv HBTU/HOBt ua ke nrog lub hauv paus xws li DIPEA) thiab pub rau hauv lub reactor. Cov pab pawg ua haujlwm carboxyl tsim ib daim ntawv cog lus ruaj khov peptide nrog dawb N-terminal amine ntawm cov khoom txhawb nqa.

Rau tirzepatide, hydrophobic thiab sterically hindered amino acid txoj hauj lwm yuav tsum tau kho qhov ua kom tsis muaj zog thiab cov tshuaj tiv thaiv ntev kom tswj tau qhov kev hloov pauv siab.

Kauj Ruam 4: Chain Elongation Cycle

Lub deprotection → ntxuav → coupling → ntxuav lub voj voog rov ua ntu zus raws li tirzepatide ib ntus, seem los ntawm residue, kom txog rau thaum tag nrho 39-amino-acid backbone tau sib sau ua ke. Qhov chaw tshwj xeeb fatty acid sab saw yog qhia nyob rau ntawm txoj hauj lwm lysine los ntawm kev xaiv deprotection thiab conjugation, ua ntej mus rau theem kawg cleavage.

Kauj Ruam 5: Cleavage & Crude Peptide tso tawm

Thaum tag nrho - ntev los ua ke tau txheeb xyuas, cov peptide sib sau ua ke yog cleaved los ntawm cov resin siv trifluoroacetic acid (TFA) cocktail nrog radical scavengers. Tus qauv cleavage cocktail rau tirzepatide yog TFA / dej / TIS ntawm 95: 3: 2 piv, nrog rau 2-3 teev cov tshuaj tiv thaiv lub sij hawm kom txo qis cov kev phiv sab thiab khaws cov fatty acid sab - saw qauv. Cov kauj ruam no ib txhij tshem tawm tag nrho cov seem sab -chain tiv thaiv pawg. Cov tshuaj cleavage yog sau, concentrated thiab precipitated kom tawm los crude tirzepatide hmoov, uas ces mus rau lub multi-theem crude peptide purification txheej txheem ntawm kev npaj RP-HPLC.

Txawm hais tias nrog cov txheej txheem ua kom zoo tshaj plaws, tag nrho cov txiaj ntsig kev sib txuas ntawm tirzepatide yog qis dua qhov luv thiab nruab nrab -ntev peptides (10-20 amino acids). Peb lub tswv yim tseem ceeb ua rau qhov kev poob qis, tag nrho cov uas loj hlob exponentially hnyav dua li cov saw ntev nce.

Deletion Sequences

Yog tias ib kauj ruam txuas ntxiv ua tsis tiav 100% ua tiav, cov pab pawg amine dawb uas tsis muaj kev cuam tshuam yuav txuas ntxiv mus txuas ntxiv mus ntxiv, tsim cov peptide chains uas ploj lawm ib qho amino acid - hu ua deletion sequences. Rau ib qho 39-amino-acid peptide, txawm tias qhov nruab nrab 99% kev sib txuas ua haujlwm ntawm ib kauj ruam ua rau tsuas yog ~ 68% ntawm cov saw hlau nqa qhov tseeb tag nrho ntev. Kev tshem tawm impurities yog cov txheej txheem zoo ib yam li lub hom phiaj peptide, ua rau lawv nyuaj heev kom tshem tawm hauv cov dej hauv qab kom huv.

Tsis tiav Coupling

Steric hindrance, amino acid hydrophobicity thiab resin matrix aggregation tag nrho txo ​​cov kev sib txuas ua haujlwm ntawm cov haujlwm tshwj xeeb. Rau tirzepatide, ntu hydrophobic nyob ib sab ntawm qhov chaw lipidation yog tshwj xeeb tshaj yog ua rau tsis tiav kev sib txuas, tsim cov truncated peptide impurities uas txo cov purity tag nrho.

Aggregation Effect

Raws li cov saw peptide txuas ntxiv, inter- chains hydrophobic kev sib cuam tshuam ua rau cov peptide loj hlob tuaj thiab sib sau ua ke ntawm cov resin nto. Qhov no faus N-terminal amine pawg nyob rau hauv compact molecular pawg, ua rau lawv nkag tsis tau rau coupling reagents. Peptide aggregation nyob rau hauv SPPS yog ib qho loj tshaj plaws ua rau yield vau rau ntev peptides zoo li tirzepatide, thiab lub hauv paus yog vim li cas ntau manufacturers tsis tuaj yeem ua tau zoo ib yam siab -purity tso zis ntawm nplai.

Cov kev sib tw tawm los uas tau piav qhia saum toj no tsis yog cais rau ib lub chaw tsim khoom ib leeg - lawv sawv cev rau lub ntiaj teb cov qauv fwj rau tag nrho kev lag luam peptide API.Raws li 2026 thoob ntiaj teb peptide kev lag luam cov ntaub ntawv tshaj tawm thiab HDM BIO cov khoom lag luam tshuaj xyuas cov ntaub ntawv hla 30+ cov chaw thoob ntiaj teb, rau 39-amino-acid class long peptides sawv cev los ntawm tirzepatide, kev ua haujlwm thoob plaws hauv kev lag luam tseem tsis tshua muaj qis, tsim cov khoom txwv tsis pub pom thoob plaws GLP-1 peptide kev lag luam hauv 2026.

Core Industry Benchmark Cov ntaub ntawv

Nruab nrab crude purity: Lub ntiaj teb no kev lag luam nruab nrab crude peptide purity rau 39AA ntev peptides yog qis dua 65%, nrog rau ntau me me thiab nruab nrab - loj manufacturers poob qis dua 55%.

Zuag qhia tag nrho yield: Los ntawm cov khoom thauj mus rau qhov kawg purified lyophilized hmoov, kev lag luam nruab nrab tag nrho cov txiaj ntsig rau tirzepatide-chav peptides tsawg dua 15%.

Tus nqi qauv: Rau ntev - chain peptides ntawm qhov ntev, RP-HPLC purification peptides tus nqi suav rau ntau dua 60% ntawm tag nrho cov nqi tsim khoom - tshaj tus nqi ntawm cov txheej txheem synthesis nws tus kheej.

Tsim nyog muaj peev xwm: Thoob ntiaj teb, tsawg dua 20 GMP-qib cov chaw ua haujlwm ua ke SPPS + npaj HPLC kab muaj peev xwm ruaj khov 30+AA ntev peptide ntau lawm. Tsuas yog ib qho me me ntawm cov no tau lees paub cov txheej txheem tsim khoom tirzepatide.

Batch sib xws: Tsis muaj kev tswj hwm kev sib sau ua ke thiab qhov sib txawv ntawm kev sib txuas ua kom zoo ua rau cov khoom siv ib txwm muaj - mus rau -batch purity fluctuations ntawm ± 3% thoob plaws hauv kev lag luam, nrog rau siab - kev pheej hmoo ua ntu zus qhia qhov txawv txav ntau dua.

Cov qauv ntsuas no piav qhia vim li cas tirzepatide API cov khoom siv tsis tuaj yeem ntsuas nrawm txawm tias muaj kev lag luam xav tau. Feem ntau cov tuam txhab lag luam tsis tuaj yeem kov yeej cov kev sib tw hauv chemistry ntawm ntev -peptide SPPS ntawm kev lag luam.

Rau cov txheej txheem txheej txheem los txheeb xyuas cov tuam txhab lag luam uas siv tau ntev -peptide muaj peev xwm tsim tau, saib peb phau ntawv qhia yuav ua li cas xaiv tus neeg muag khoom tirzepatide API txhim khu kev qha.

Qhov sib txawv ntawm cov txheej txheem peptide ntau lawm thiab tirzepatide ntau lawm, thiab kev ua tau zoo ntawm cov txheej txheem kev lag luam zoo, tau sau tseg hauv cov lus hauv qab no:

Cov tuam txhab peptide tau tsim cov txheej txheem kev ua kom zoo los tiv thaiv kev lag luam -ntev ntev -peptide yield bottleneck, tshwj xeeb calibrated rau tirzepatide amino acid sequence.

Lub Sijhawm Coupling txuas ntxiv rau ntu nyuaj

Rau hydrophobic thiab sterically hindered txoj hauj lwm nyob rau hauv lub tirzepatide ib theem zuj zus, ncua sij hawm coupling tshaj lub sij hawm tus qauv tso cai rau reagents diffuse mus rau hauv ib nrab aggregated resin domains, txhim kho cov tshuaj tiv thaiv tiav. Qhov no yog ib qho yooj yim tab sis muaj txiaj ntsig zoo rau kev txo qis kev tshem tawm impurity tsim.

Ob chav Coupling raws tu qauv

Ntawm qhov siab - txoj haujlwm txaus ntshai tau txheeb xyuas los ntawm kev soj ntsuam ib ntus thiab cov ntaub ntawv tsim khoom siv tau, ib qho thib ob ntawm cov amino acid tshiab tau qhia tom qab thawj qhov kev sib txuas lus. Ob chav txuas tuaj yeem nce ib - kauj ruam hloov pauv los ntawm ~ 98% mus rau ntau dua 99.5%, xa cov kev txhim kho loj heev hauv tag nrho -ntev peptide tawm los hla 38 cov kauj ruam elongation.

Optimized Protected Amino Acid Xaiv

Siv tshwj xeeb hloov Fmoc amino acids nrog pseudo-proline los yog sab-chain solubilizing pab cuam cuam tshuam inter-chain hydrophobic kev sib cuam tshuam, ua kom cov saw peptide loj hlob nyob rau hauv kev sib txuas ntxiv thiab siv tau rau cov tshuaj reagents. Rau tirzepatide, lub hom phiaj hloov pauv ntawm qhov tseem ceeb hydrophobic residues nrog optimized tiv thaiv amino acids ho txo ​​cov aggregation - cuam tshuam yield poob.

Ntawm HDM BIO, peb tau ua kom zoo dua tirzepatide- tshwj xeeb SPPS raws tu qauv sib txuas tag nrho peb lub tswv yim, nce crude peptide purity mus rau 70-75% - zoo tshaj qhov nruab nrab ntawm kev lag luam.<65%. This reduces downstream purification burden by approximately 20%, shortens production cycles, and supports stable supply of ≥98% purity tirzepatide API for both small-batch R&D and large-scale industrial orders. Our process also delivers batch-to-batch purity variation of ≤1%, far exceeding industry consistency standards.

Phau ntawv qhia no rhuav tshem tag nrho SPPS peptide synthesis mechanism rau tirzepatide, npog cov ntsiab lus tseem ceeb los ntawm Fmoc chemistry cov ntsiab lus tseem ceeb thiab peptide chain elongation chemistry mus ntev peptide kev sib tw, cov txheej txheem peptide purification crude, thiab industrial GLP-1 peptide synthesis} txheej txheem nce. Nws kuj tseem qhia txog cov ntsiab lus ntawm cov khoom theem resin chemistry, Fmoc deprotection mechanism, hauv paus ua rau peptide aggregation hauv SPPS, thiab RP-HPLC purification peptidesworkflows xav tau rau siab -purity API ntau lawm.

Q: Tirzepatide puas tuaj yeem tsim nrog kua -theem peptide synthesis?

A: Tsis yog. Rau 39-amino-acid peptide nrog cov lipidated sab saw, kua-theem synthesis yuav xav tau kaum ob ntawm cov kauj ruam purification nruab nrab, uas ua rau tsis tshua muaj txiaj ntsig tag nrho thiab tsis muaj kev lag luam muaj txiaj ntsig. Txhua qhov kev lag luam tirzepatide API yog tsim los ntawm Fmoc SPPS.

Q: Ntev npaum li cas ib pawg ntawm tirzepatide SPPS synthesis siv sijhawm?

A: Cov khoom sib dhos- theem sib dhos rau tag nrho -ntev tirzepatide batch feem ntau yuav siv sijhawm 7-10 hnub, nyob ntawm seb qhov loj me thiab cov naj npawb ntawm optimized ob -coupling txoj haujlwm. Qhov no tsis suav nrog HPLC purification thiab lyophilization cov kauj ruam tom ntej.

Q: Dab tsi yog qhov purity purity ntawm tirzepatide tom qab SPPS?

A: Nrog rau cov txheej txheem SPPS cov txheej txheem, crude tirzepatide purity ranges ntawm 55–65%, raws li kev lag luam thoob ntiaj teb nruab nrab rau 39AA peptides. Nrog rau cov txheej txheem kev lag luam zoo nrog rau ob qho kev sib txuas thiab kev sib sau ua ke -cov qauv tsim cov amino acid resistant, crude purity tuaj yeem ncav cuag 70-75% ua ntej purification downstream.

Q: Dab tsi coupling reagents yog siv rau tirzepatide SPPS?

A: Muaj tirzepatide ntau lawm feem ntau siv HBTU / HOBt raws li tus qauv sib txuas reagent system rau feem ntau cov seem. Rau qhov nyuaj hydrophobic ntu nrog kev pheej hmoo siab sib sau ua ke, HATU yog siv los ua kom muaj zog dua thiab txhim kho kev sib txuas ua haujlwm.

Q: Puas yog tirzepatide siv Boc lossis Fmoc synthesis?

A: Txhua yam kev lag luam niaj hnub tirzepatide API ntau lawm siv Fmoc-raws li SPPS. Lub tswv yim Boc yuav tsum muaj cov kua qaub hnyav dua thiab rov ua HF cleavage cov kauj ruam, uas tsis sib haum nrog cov molecule rhiab fatty acid sab - saw hloov thiab yuav ua rau muaj kev cuam tshuam ntau dhau.

Q: Yuav ua li cas txo peptide aggregation thaum lub sij hawm tirzepatide synthesis?

A: Cov tswv yim pom zoo muaj xws li kev txhim kho resin loading ceev kom txo tau cov inter- chain interactions, pseudo-proline amino acid hloov ntawm hydrophobic sites, ncua sij hawm txuas ntxiv rau cov ntu nyuaj, ob chav coupling raws tu qauv rau siab - txoj haujlwm txaus ntshai, thiab kev tswj xyuas qhov kub thiab txias.